According to Fresenius Medical Care's latest financial reports the company has $1.47 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $1.54 B | -15.62% |
2021-12-31 | $1.83 B | 19.83% |
2020-12-31 | $1.52 B | 19.63% |
2019-12-31 | $1.27 B | -47.93% |
2018-12-31 | $2.45 B | 109.1% |
2017-12-31 | $1.17 B | 15.96% |
2016-12-31 | $1.01 B | 23.25% |
2015-12-31 | $0.82 B | 2.43% |
2014-12-31 | $0.80 B | 17.46% |
2013-12-31 | $0.68 B | -0.78% |
2012-12-31 | $0.68 B | 50.5% |
2011-12-31 | $0.45 B | -12.56% |
2010-12-31 | $0.52 B | 73.61% |
2009-12-31 | $0.30 B | 35.36% |
2008-12-31 | $0.22 B | -9.19% |
2007-12-31 | $0.24 B | 53.86% |
2006-12-31 | $0.15 B | 87.63% |
2005-12-31 | $84.88 M | 43.86% |
2004-12-31 | $59 M | 21.88% |
2003-12-31 | $48.41 M | -27.72% |
2002-12-31 | $66.97 M | -10.77% |
2001-12-31 | $75.06 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() Amgen AMGN | $34.24 B | 2,214.90% | ๐บ๐ธ USA |
![]() Baxter BAX | $1.72 B | 16.39% | ๐บ๐ธ USA |
![]() DaVita DVA | $0.33 B | -77.02% | ๐บ๐ธ USA |
![]() IDEXX Laboratories IDXX | $0.13 B | -91.02% | ๐บ๐ธ USA |
![]() Quest Diagnostics
DGX | $0.12 B | -91.48% | ๐บ๐ธ USA |
![]() Teleflex TFX | $0.25 B | -83.05% | ๐บ๐ธ USA |
![]() LabCorp LH | $1.93 B | 30.49% | ๐บ๐ธ USA |
![]() Rockwell Medical
RMTI | $8.95 M | -99.39% | ๐บ๐ธ USA |